Q1 2022 13F Holders as of 31 Mar 2022
-
Type / Class
-
Equity / COM CL A
-
Total 13F shares
-
14,204,446
-
Share change
-
-218,572
-
Total reported value
-
$138,649,000
-
Price per share
-
$9.76
-
Number of holders
-
39
-
Value change
-
-$2,072,904
-
Number of buys
-
16
-
Number of sells
-
9
Institutional Holders of RESEARCH ALLIANCE CORP II - COM CL A (RACB) as of Q1 2022
As of 31 Mar 2022,
RESEARCH ALLIANCE CORP II - COM CL A (RACB) was held by
39 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
14,204,446 shares.
The largest 10 holders included
HealthCor Management, L.P., Sculptor Capital LP, Bain Capital Life Sciences Investors, LLC, PERCEPTIVE ADVISORS LLC, CITADEL ADVISORS LLC, Alyeska Investment Group, L.P., Laurion Capital Management LP, FARALLON CAPITAL MANAGEMENT LLC, Woodline Partners LP, and RTW INVESTMENTS, LP.
This page lists
39
institutional shareholders reporting positions in this security
for the Q1 2022 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.